E. Boyle

Statistics

Publications

Citations

352

H-Index

Active since

2018

Affiliations

Centre Hospitalier Universitaire de Lille(Current)

Inserm

E. Boyle is an author at Centre Hospitalier Universitaire de Lille specializing in ultra-performance liquid chromatography-mass spectrometry, metabolite assay development, and primary central nervous system lymphoma therapy.

Publications per year

2018–2019

Publications

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Carole Soussain, Sylvain Choquet, Marie Blonski et al. · European Journal of Cancer · 2019 · 318 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid

David Beauvais, J.-F. Goossens, E. Boyle et al. · Journal of Chromatography B · 2018 · 34 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

1–2 of 2